The ABA is thankful for the continued support and partnership of our exhibitors and sponsors!

Spend some time to learn about all of the companies and what they have to offer!  Learn about products and services that can improve burn care and rehabilitation. These companies help to make the ABA events possible.

BARDA

Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, was established to aid in securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID).

Community Tissue Services offers physicians and their patients’ biologic allograft solutions. Our goal is to provide safe and efficacious allografts while seeking innovative biologic solutions for patients. Our state of the art Center for Tissue, Innovation and Research works to develop technologies to stimulate the biologic properties of allografts.

Exsurco Medical is a medical device manufacturer of high precision skin grafting and excision products for tissue banks and surgery. Our mission is to redefine excision science across the continuum of care through delivery and advancements in clinical solutions, strategic healthcare partnerships, and deep customer understanding.

Hospital Therapy Products

Manufacture of Hydrotherapy equipment, for the treatment of burns. Disposable privacy curtains.

UltraPulse® can penetrate deeper than any aesthetic ablative CO2 laser. Combined with great versatility, this makes UltraPulse® perfect for both everyday procedures and the thick and complex lesions.

Mallinckrodt is a global business that develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies.

MicroGenDX

MicroGenDX is the leader in providing comprehensive DNA analysis for infections. Using Next Generation DNA Sequencing (NGS), we identify causative microbes and match DNA sequence codes of 30,000+ microbial species with 99.9% accuracy. MicroGenDX provides physicians with precise information needed to make confident treatment decisions.

PolarityTE

PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. PolarityTE’s innovative method is intended to promote and accelerate growth of the patient’s tissues to undergo a form of effective regenerative healing.

PolyNovo

PolyNovo is the developer of unique, patended, biodegradable polymers for use in medical devices. Novosorb® BTM was developed with our innovative technology providing physicians a clinically proven matrix for partial and full thickness wounds, pressure, venous and diabetic ulcers, chronic and vascular ulcers, surgical, trauma and draining wounds.

BTM (Biodegradable Temporising Matrix) is entirely synthetic and has been developed for use as an implantable dressing on complex open wounds (too large to be closed by suturing) and major burns. Following placement onto the wound, blood vessels and fibroblasts migrate into the foam scaffold over three to four weeks (stylised figures). During this time, the fibroblasts manufacture collagen creating a connective tissue scaffold to replace the biodegrading foam, resulting in a dermis-like layer. Once integrated with vascularised tissue, the seal is peeled away (delamination) and the wound surface reconstructed with a split skin graft. Wound cover with BTM therefore offers a reconstruction which is thicker, more durable and more aesthetic than immediate split-skin grafting.

Stellen Medical LLC

Stellen Medical, LLC (formally Brennen Medical) is the manufacturer and distributor of GlucanPro 3000, GlucanPro Cream, Glucan II, Nova Gel, and the Brennen Skin Graft Mesher. Our Glucan products are derived from proprietary Oat Beta Glucan technology. The Brennen Skin Graft Mesher is a standard in the Burn Industry.

Vericel Corporation

Vericel develops, manufactures, and markets autologous cell-based therapies. Epicel® (cultured epidermal autografts) is a skin graft grown from a patient’s own skin. These grafts provide skin replacement for patients who have deep dermal or full thickness burns comprising a total body surface area of greater than or equal to 30%.

Vericel is committed to improving the lives of patients with serious conditions by developing and manufacturing innovative cell therapies and specialty biologics.

Participation by an exhibitor or sponsor in the ABA Annual Meeting does not imply endorsement or approval by ABA of any product, service, company, or participant and none shall be claimed by any participant.